The Effect of Ketamine Infusion on Lumbar Surgery
1 other identifier
interventional
56
1 country
1
Brief Summary
The purpose of this study is to evaluate the effect of ketamine infusion for reduction of neuropathic pain and improvement of quality of life after lumbar surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started May 2014
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 25, 2014
CompletedFirst Posted
Study publicly available on registry
June 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedJune 3, 2014
May 1, 2014
11 months
May 25, 2014
May 29, 2014
Conditions
Outcome Measures
Primary Outcomes (3)
Pain Scores on the Visual Analog Scale
VAS score in 1 day before lumbar surgery
1 day before lumbar surgery
Pain Scores on the Visual Analog Scale
VAS score in 1 month after lumbar surgery
1 month after lumbar surgery
Pain Scores on the Visual Analog Scale
VAS score in 3 month after lumbar surgery
3 month after lumbar surgery
Secondary Outcomes (12)
Leeds assessment of neuropathic symptoms and signs (LANSS) score
1 day before lumbar surgery
Leeds assessment of neuropathic symptoms and signs (LANSS) score
1 month after lumbar surgery
Leeds assessment of neuropathic symptoms and signs (LANSS) score
3 month after lumbar surgery
neuropathic pain scale (NPS) score
1 day before lumbar surgery
neuropathic pain scale (NPS) score
1 month after lumbar surgery
- +7 more secondary outcomes
Study Arms (2)
ketamine
EXPERIMENTALketamine 0.5mg/kg loading dose and followed by 0.5mg/kg/h during operation
Placebo
PLACEBO COMPARATORnormal saline 0.5mg/kg loading dose and followed by 0.5mg/kg/h during operation
Interventions
ketamine 0.5mg/kg loading followed by 0.5mg/kg/h infusion during operation
Eligibility Criteria
You may qualify if:
- Undergoing lumbar spine surgery due to back pain patients
- American Physical Status Classification I or II
You may not qualify if:
- less than 3 month of back pain
- past history of operation at lumbar area
- past history of glucoma, drug abuse, alcohol abuse
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gangnam Severance Hospital
Seoul, 135-720, South Korea
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kyung Hyun Kim, MD
Department of Neurosurgery, The Spine and Spinal Cord Institute, Gangnam Severance Spine Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical assistant professor
Study Record Dates
First Submitted
May 25, 2014
First Posted
June 3, 2014
Study Start
May 1, 2014
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
June 3, 2014
Record last verified: 2014-05